Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
Kawasaki disease (KD) is a type of febrile self-limiting systemic vasculitis, which affects the coronary arteries (CA) and may cause cardiac ischemia during childhood and adult life. Intravenous immunoglobulin (IVIG) has become the standard therapy for KD. However, it is still uncertain if CA outcom...
Saved in:
| Main Authors: | Aswine K. Bal, Deepa Prasad, Maria Angela Umali Pamintuan, Elizabeth Mammen-Prasad, Anna Petrova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2014-10-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S187595721400028X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024-09-01) -
Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease
by: Serkan Türkuçar, et al.
Published: (2020-02-01) -
Analysis of the clinical characteristics of patients with Kawasaki disease complicated with cholestasis
by: Pingping Yang, et al.
Published: (2024-11-01) -
Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center Experience
by: Cristina Ramona Rădulescu, et al.
Published: (2025-03-01) -
Case Series on the Efficacy and Safety of Tocilizumab in IVIG-Resistant Kawasaki Disease: A Retrospective Analysis of Five Patients
by: Ling J, et al.
Published: (2024-12-01)